EUVIMEDEUVIMED entdecken
Crossref

Quinolinic acid contributes to maladaptive kidney injury and acute kidney injury–to–chronic kidney disease transition

Marie Christelle Saade iD, Afaf Saliba iD, Amanda J Clark iD, Subrata Debnath, Shiqi Zhang iD, Nagarjunachary Ragi iD, Valerie Etzrodt, Rahil Al-Humaidi iD, Kyle Vu iD, Yu Tao iD, Esmeralda Trevino, Alejandra L Lorenzen iD und 5 weitere

Science Translational Medicine · 14.10.2026 · 18 (871)

DOI: 10.1126/scitranslmed.aec9689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 14.10.2026. Verfasst von Marie Christelle Saade und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Department of Internal Medicine, University of Texas Southwestern, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Acute Kidney Injury, Quinolinic Acid, Renal Insufficiency, Chronic, Disease Progression. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Institute of Diabetes and Digestive and Kidney Diseases, NHLBI Division of Intramural Research, Alkaptonuria Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The transition from acute kidney injury (AKI) to chronic kidney disease (CKD) remains a major clinical problem with unclear underlying mechanisms. Emerging evidence suggests that alterations in tryptophan metabolism, particularly in the production of downstream metabolites such as quinolinic acid (QA), play a role in renal pathophysiology. QA, an intermediate in de novo nicotinamide adenine dinucleotide biosynthesis, is metabolized by quinolinate phosphoribosyltransferase (QPRT). We investigated whether QA contributes to kidney injury using models of folic acid–induced AKI-to-CKD transition and cisplatin-induced AKI, genetic and exogenous approaches to alter QA, and clinical observations. Untargeted kidney metabolomics identified QA as one of the most elevated metabolites after folic acid injury. After folic acid injury, Qprt haploinsufficiency exacerbated kidney injury and fibrosis-related gene expression; aged Qprt -haploinsufficient mice exhibited increased fibrosis-associated gene expression without overt renal dysfunction. Exogenous QA administration increased serum creatinine in uninjured mice and worsened renal dysfunction and fibrosis-related gene expression in the folic acid AKI-to-CKD model. Conversely, mice deficient in either 3-hydroxyanthranilate 3,4-dioxygenase (HAAO) or kynurenine 3-monooxygenase (KMO), which reduce flux toward QA, showed improved renal outcomes after folic acid injury and cisplatin-induced AKI. Multimodal spatial metabolomics analysis of kidney biopsies from patients with AKI revealed QA accumulation in regions of inflammatory infiltration. Last, children with CKD exhibited higher urinary QA compared with healthy individuals. These findings underscore QA as a potential mediator of kidney injury and a therapeutic target for preventing the progression from AKI to CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryQuinolinic AcidRenal Insufficiency, ChronicDisease ProgressionAnimalsHumansFolic AcidFibrosisMaleNicotinate-Nucleotide Diphosphorylase (Carboxylating)KidneyCisplatinMice, Inbred C57BLDisease Models, AnimalPentosyltransferasesMetabolomics

Substanzen

Quinolinic AcidFolic AcidNicotinate-Nucleotide Diphosphorylase (Carboxylating)CisplatinPentosyltransferases

Autor:innen und Institutionen

  • Division of Nephrology and Department of Internal Medicine, University of Texas Southwestern, Dallas, TX 75390, USA.
  • Division of Nephrology, Department of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
  • Center for Precision Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
  • Center for the Genetics of Host Defense, University of Texas Southwestern, Dallas, TX 75390, USA.
  • Division of Pediatric Nephrology and Department of Pediatrics, University of Texas Southwestern and Children's Medical Center, Dallas, TX 75235, USA.
  • Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, USA.

ORCID-Profile: Marie Christelle Saade, Afaf Saliba, Amanda J Clark, Shiqi Zhang, Nagarjunachary Ragi, Rahil Al-Humaidi, Kyle Vu, Yu Tao, Alejandra L Lorenzen, Guanshi Zhang, Anders H Berg, Samir M Parikh, Kumar Sharma

Förderung

  • National Institute of Diabetes and Digestive and Kidney Diseases
  • NHLBI Division of Intramural Research
  • Alkaptonuria Society

Zitieren

APA

Saade, M. C., Saliba, A., Clark, A. J., Debnath, S., Zhang, S., Ragi, N., Etzrodt, V., Al-Humaidi, R., Vu, K., Tao, Y., Trevino, E., Lorenzen, A. L., Zhang, G., Berg, A. H., O'Connor, J. C., Parikh, S. M., & Sharma, K. (2026). Quinolinic acid contributes to maladaptive kidney injury and acute kidney injury–to–chronic kidney disease transition. Science Translational Medicine, 18(871). https://doi.org/10.1126/scitranslmed.aec9689

Vancouver

Saade MC, Saliba A, Clark AJ, Debnath S, Zhang S, Ragi N, et al. Quinolinic acid contributes to maladaptive kidney injury and acute kidney injury–to–chronic kidney disease transition. Science Translational Medicine. 2026;18(871). doi:10.1126/scitranslmed.aec9689

BibTeX
@article{Saade2026,
  author = {Saade, Marie Christelle and Saliba, Afaf and Clark, Amanda J and Debnath, Subrata and Zhang, Shiqi and Ragi, Nagarjunachary and Etzrodt, Valerie and Al-Humaidi, Rahil and Vu, Kyle and Tao, Yu and Trevino, Esmeralda and Lorenzen, Alejandra L and Zhang, Guanshi and Berg, Anders H and O'Connor, Jason C and Parikh, Samir M and Sharma, Kumar},
  title = {Quinolinic acid contributes to maladaptive kidney injury and acute kidney injury–to–chronic kidney disease transition},
  journal = {Science Translational Medicine},
  year = {2026},
  volume = {18},
  number = {871},
  doi = {10.1126/scitranslmed.aec9689}
}
Kostenlos starten →